The Center for Translational Pathology (CTP) will provide investigators with high quality, state of the art, and cost-effective tissue-based and clinical laboratory assays, biospecimens, consultative pathology services, multiparametric imaging, mass spectrometry, molecular pathology, mouse models and advanced cellular therapeutics for basic, translational, and clinical research. Originally established in 2007 as the Translational Research Program (TRP) within the Department of Pathology & Laboratory Medicine at Weill Cornell Medicine, the TRP has since grown and expanded to include numerous core facilities within the Department of Pathology & Laboratory Medicine. This new center will be a pillar for the Meyer Cancer Center and its designation as an NCI Comprehensive Cancer Center.

Facility serves as central facility for human organoid technology to accelerate organoid-based scientific discovery. Provides human pluripotent stem cell (hPSC) derived as well as tissue derived cells and organoids.